Right ventricular dysfunction in left ventricular assist device candidates: is it time to change our prospective?


Journal

Heart failure reviews
ISSN: 1573-7322
Titre abrégé: Heart Fail Rev
Pays: United States
ID NLM: 9612481

Informations de publication

Date de publication:
Mar 2024
Historique:
accepted: 24 01 2024
medline: 18 3 2024
pubmed: 8 2 2024
entrez: 8 2 2024
Statut: ppublish

Résumé

The use of left ventricular assist devices (LVAD) has significantly increased in the last years, trying to offer a therapeutic alternative to heart transplantation, in light also to the significant heart donor shortage compared to the growing advanced heart failure population. Despite technological improvements in the devices, LVAD-related mortality is still fairly high, with right heart failure being one of the predominant predictors. Therefore, many efforts have been made toward a thorough right ventricular (RV) evaluation prior to LVAD implant, considering clinical, laboratory, echocardiographic, and invasive hemodynamic parameters. However, there is high heterogeneity regarding both which predictor is the strongest as well as the relative cut-off values, and a consensus has not been reached yet, increasing the risk of facing patients in which the distinction between good or poor RV function cannot be surely reached. In parallel, due to technological development and availability of mechanical circulatory support of the RV, LVADs are being considered even in patients with suboptimal RV function. The aim of our review is to analyze the current evidence regarding the role of RV function prior to LVAD and its evaluation, pointing out the extreme variability in parameters that are currently assessed and future prospective regarding new diagnostic tools. Finally, we attempt to gather the available information on the therapeutic strategies to use in the peri-operative phase, in order to reduce the incidence of RV failure, especially in patients in which the preoperative evaluation highlighted some conflicting results with regard to ventricular function.

Identifiants

pubmed: 38329583
doi: 10.1007/s10741-024-10387-w
pii: 10.1007/s10741-024-10387-w
pmc: PMC10942886
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

559-569

Informations de copyright

© 2024. The Author(s).

Références

Eur J Cardiothorac Surg. 2021 Jul 14;60(1):177-185
pubmed: 33783490
Circulation. 2013 Oct 29;128(18):2005-15
pubmed: 24056689
J Cardiovasc Ultrasound. 2017 Jun;25(2):39-46
pubmed: 28770031
J Card Surg. 2021 Jun;36(6):1996-2003
pubmed: 33834522
Int J Cardiol. 2016 Sep 1;218:150-157
pubmed: 27232927
Circ Heart Fail. 2022 Jun;15(6):e008706
pubmed: 35658464
ASAIO J. 2018 Nov/Dec;64(6):741-747
pubmed: 29210774
J Thorac Dis. 2019 Apr;11(Suppl 6):S864-S870
pubmed: 31183166
J Card Fail. 2013 Jan;19(1):16-24
pubmed: 23273590
Interact Cardiovasc Thorac Surg. 2020 Apr 1;30(4):499-506
pubmed: 31986207
Crit Care Med. 2007 Mar;35(3):707-15
pubmed: 17255859
J Heart Lung Transplant. 2012 Feb;31(2):140-9
pubmed: 22168963
J Heart Lung Transplant. 2016 Jan;35(1):67-73
pubmed: 26212656
Acta Cardiol Sin. 2019 Nov;35(6):585-591
pubmed: 31879509
J Card Fail. 2015 Jun;21(6):519-34
pubmed: 25953697
Curr Opin Cardiol. 2011 Mar;26(2):123-31
pubmed: 21297465
Ann Thorac Surg. 2013 Sep;96(3):857-63; discussion 863-4
pubmed: 23791165
Am J Cardiol. 2006 Dec 1;98(11):1489-92
pubmed: 17126656
Front Cardiovasc Med. 2022 Apr 28;9:888136
pubmed: 35571194
J Card Surg. 2020 Aug;35(8):1832-1839
pubmed: 32557925
ASAIO J. 2018 Nov/Dec;64(6):e140-e147
pubmed: 29746312
Circulation. 2002 Sep 24;106(12 Suppl 1):I198-202
pubmed: 12354733
Int J Cardiol. 2015 Nov 1;198:241-50
pubmed: 26232775
J Heart Lung Transplant. 2020 Aug;39(8):735-750
pubmed: 32386998
Int J Cardiovasc Imaging. 2022 Mar;38(3):561-570
pubmed: 34661853
ESC Heart Fail. 2022 Apr;9(2):1487-1491
pubmed: 35083882
Eur J Cardiothorac Surg. 2020 Jan 1;57(1):176-182
pubmed: 31155645
ASAIO J. 2020 Jun;66(6):610-619
pubmed: 31651460
J Am Coll Cardiol. 2008 Jun 3;51(22):2163-72
pubmed: 18510965
J Am Coll Cardiol. 1999 Sep;34(3):730-8
pubmed: 10483954
J Cardiothorac Vasc Anesth. 2016 Jun;30(3):619-26
pubmed: 27321789
Circulation. 2013 Sep 10;128(11 Suppl 1):S14-23
pubmed: 24030398
Artif Organs. 2013 Jun;37(6):523-30
pubmed: 23550592
Artif Organs. 2019 Jul;43(7):624-632
pubmed: 30592069
JAMA. 2022 Sep 27;328(12):1233-1242
pubmed: 36074476
J Cardiothorac Vasc Anesth. 2016 Jun;30(3):627-31
pubmed: 26460277
Am J Cardiol. 2010 Apr 1;105(7):1030-5
pubmed: 20346326
Eur Heart J. 2014 Jun 21;35(24):1608-16
pubmed: 24014387
J Heart Lung Transplant. 2021 Aug;40(8):778-785
pubmed: 34167863
Eur Respir J. 2015 Mar;45(3):700-8
pubmed: 25359353
J Am Coll Cardiol. 2012 Aug 7;60(6):521-8
pubmed: 22858287
Med Sci Monit Basic Res. 2016 May 05;22:53-7
pubmed: 27145697
Interact Cardiovasc Thorac Surg. 2021 Oct 29;33(5):784-792
pubmed: 34368839
Circulation. 2018 Feb 27;137(9):891-906
pubmed: 28847897
J Cardiothorac Surg. 2022 Jun 16;17(1):158
pubmed: 35710438
Eur J Heart Fail. 2017 Jul;19(7):926-946
pubmed: 28371221
J Am Coll Cardiol. 2013 Jan 22;61(3):313-21
pubmed: 23265328
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Circ J. 2015;79(3):478-86
pubmed: 25746523
J Heart Lung Transplant. 2019 Feb;38(2):114-126
pubmed: 30691593
N Engl J Med. 2023 Mar 23;388(12):1111-1125
pubmed: 36947468
Arch Cardiovasc Dis. 2015 May;108(5):300-9
pubmed: 25863429
J Heart Lung Transplant. 2013 Aug;32(8):777-83
pubmed: 23773508
J Heart Lung Transplant. 2008 Oct;27(10):1102-7
pubmed: 18926401
J Cardiothorac Vasc Anesth. 2020 May;34(5):1204-1210
pubmed: 31558395
J Thorac Cardiovasc Surg. 2010 May;139(5):1316-24
pubmed: 20132950
J Thorac Dis. 2021 Feb;13(2):1256-1269
pubmed: 33717597
J Cardiol. 2022 Aug;80(2):110-115
pubmed: 34974940
ASAIO J. 2012 Jan-Feb;58(1):6-11
pubmed: 22157071
J Cardiol. 2017 Oct;70(4):303-309
pubmed: 28325519
Ann Thorac Surg. 2019 Jun;107(6):1768-1774
pubmed: 30582926
J Heart Lung Transplant. 2008 Dec;27(12):1286-92
pubmed: 19059108
Interact Cardiovasc Thorac Surg. 2019 May 1;28(5):674-682
pubmed: 30561630
J Clin Med. 2022 Jan 26;11(3):
pubmed: 35160064
Expert Rev Med Devices. 2019 Aug;16(8):663-673
pubmed: 31216915

Auteurs

Carlotta Sciaccaluga (C)

Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy. carlotta.sciaccaluga@gmail.com.

Maria Cristina Procopio (MC)

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Luciano Potena (L)

Heart Failure and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Marco Masetti (M)

Heart Failure and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Sonia Bernazzali (S)

Department of Cardiac Surgery, University of Siena, Siena, Italy.

Massimo Maccherini (M)

Department of Cardiac Surgery, University of Siena, Siena, Italy.

Federico Landra (F)

Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.

Francesca Maria Righini (FM)

Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.

Matteo Cameli (M)

Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.

Serafina Valente (S)

Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH